0.2252.60% ( -0.006 )
Delay Closed: Nov 16, 16:08:00Financials
Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: CHANGMAO BIO(00954) the Revenue is 167.22 M (+12.09%);the EBIT is 4.768 M (+143.4%);the EPS is -0.0054 (+79.84%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.17B12.09%
----
----
EBIT
0.00B143.36%
----
----
EPS
-0.005479.84%
----
----
Upcoming earnings report - FY2026 Q3 Earning Release
Available dateNov 18, 2026
Estimate Revenue--
Estimate EBIT--
Estimate EPS--
Revenue
ActualEstimateUnit: HKD
Quarterly
EBIT
ActualEstimateUnit: HKD
Quarterly
Net income
ActualEstimateUnit: HKD
Quarterly
EPS
ActualEstimateUnit: HKD
Quarterly
